Copyright
©The Author(s) 2024.
Figure 2 Nomogram was developed to predict disease control rate of adenocarcinoma of the esophagogastric junction after three cycles of neoadjuvant chemotherapy with docetaxel, oxaliplatin and S-1.
DCR: Disease control rate.
- Citation: Zhou CQ, Gao D, Gui Y, Li NP, Guo WW, Zhou HY, Li R, Chen J, Zhang XM, Chen TW. Computed tomography-based nomogram of Siewert type II/III adenocarcinoma of esophagogastric junction to predict response to docetaxel, oxaliplatin and S-1. World J Radiol 2024; 16(1): 9-19
- URL: https://www.wjgnet.com/1949-8470/full/v16/i1/9.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i1.9